BCX7353

Upcoming events – key tests approach for Biogen and Kalvista
EP Vantage
Fri, 05/24/19 - 10:42 am
Biogen
BIIB098
Tecfidera
multiple sclerosis
KalVista
HAE
Biocryst
BCX7353
KVD900
BioCryst shares are blasted as a PhIII HAE 'success' underwhelms analysts
Endpoints
Tue, 05/21/19 - 09:51 am
Biocryst
HAE
clinical trials
BCX7353
BioCryst says oral drug works for HAE attacks
Fierce Biotech
Tue, 09/4/18 - 11:02 am
Biocryst
BCX7353
clinical trials
HAE
hereditary angiodema
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Tue, 03/29/16 - 10:33 pm
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab